Vitamin D Supplementation in Diabetic Nephropathy
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.
Also called NCT01476501
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 120 participants
- Sponsor
- Registry
-
NCT01476501
-
- Other papers using this trial's data
- Vitamin D3 supplementation, bone health and quality of life in adults with diabetes and chronic kidney disease: Results of an open label randomized clinical trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Canada
- Registry status
- Completed
Technical summary
Registry record NCT01476501. Randomized; no masking; primary purpose treatment. Start 2011-10 (registry gives no type); primary completion 2014-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Vitamin D Supplementation in Diabetic Nephropathy
- Condition
- Sub-optimal Vitamin D Status
- Condition
- Bone Disease
- Condition
- Diabetic Nephropathy
- Intervention (Drug)
- Vitamin D3
- Lead sponsor
- University of Alberta
Record details
- Record id
cardio:ct-nct01476501- Content hash
2dcb83971de9c50c112feee76f55b5b709a4212a819b68007404bfc085294f6b